These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6707230)

  • 21. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
    Pak CY; Koenig K; Khan R; Haynes S; Padalino P
    J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
    Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
    J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis.
    Seltzer MA; Low RK; McDonald M; Shami GS; Stoller ML
    J Urol; 1996 Sep; 156(3):907-9. PubMed ID: 8709360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
    Nicar MJ; Peterson R; Pak CY
    J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A; Esposito N; Castelnuovo C
    Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.
    Schwille PO; Herrmann U; Wolf C; Berger I; Meister R
    Urol Res; 1992; 20(2):145-55. PubMed ID: 1553790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citrate and renal calculi: new insights and future directions.
    Pak CY
    Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of meal on the physiological and physicochemical actions of potassium citrate.
    Pak CY; Oh MS; Baker S; Morris JS
    J Urol; 1991 Sep; 146(3):803-5. PubMed ID: 1875495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting.
    Nicar MJ; Hsu MC; Fetner C
    Clin Ther; 1986; 8(2):219-25. PubMed ID: 3698069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypocitraturia in calcium nephrolithiasis.
    Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients.
    Domrongkitchaiporn S; Khositseth S; Stitchantrakul W; Tapaneya-olarn W; Radinahamed P
    Am J Kidney Dis; 2002 Feb; 39(2):383-91. PubMed ID: 11840381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of sodium citrate and oral potassium citrate on urease-induced crystallization.
    Wang YH; Grenabo L; Hedelin H; Pettersson S
    Br J Urol; 1994 Oct; 74(4):409-15. PubMed ID: 7820416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium bioavailability from calcium carbonate and calcium citrate.
    Nicar MJ; Pak CY
    J Clin Endocrinol Metab; 1985 Aug; 61(2):391-3. PubMed ID: 4008614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy.
    Tosukhowong P; Borvonpadungkitti S; Prasongwatana V; Tungsanga K; Jutuporn S; Dissayabutr T; Reungjui S; Sriboonlue P
    Clin Chim Acta; 2002 Nov; 325(1-2):71-8. PubMed ID: 12367768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.